An eHealth System Supporting Palliative Care for Patients with Non-Small Cell Lung Cancer: A Randomized Trial by Gustafson, David H. et al.
University of Kentucky
UKnowledge
Community & Leadership Development Faculty
Publications Community & Leadership Development
5-1-2013
An eHealth System Supporting Palliative Care for
Patients with Non-Small Cell Lung Cancer: A
Randomized Trial
David H. Gustafson
University of Wisconsin–Madison
Lori L. DuBenske
University of Wisconsin–Madison
Kang Namkoong
University of Kentucky, kang.namkoong@uky.edu
Robert Hawkins
University of Wisconsin–Madison
Ming-Yuan Chih
University of Wisconsin–Madison, m.chih@uky.edu
See next page for additional authors
Right click to open a feedback form in a new tab to let us know how this document benefits you.
Follow this and additional works at: https://uknowledge.uky.edu/cld_facpub
Part of the Communication Technology and New Media Commons, Co munity-Based
Research Commons, Medicine and Health Commons, Palliative Care Commons, and the
Telemedicine Commons
This Article is brought to you for free and open access by the Community & Leadership Development at UKnowledge. It has been accepted for
inclusion in Community & Leadership Development Faculty Publications by an authorized administrator of UKnowledge. For more information,
please contact UKnowledge@lsv.uky.edu.
Repository Citation
Gustafson, David H.; DuBenske, Lori L.; Namkoong, Kang; Hawkins, Robert; Chih, Ming-Yuan; Atwood, Amy K.; Johnson, Roberta;
Bhattacharya, Abhik; Carmack, Cindy L.; Traynor, Anne M.; Campbell, Toby C.; Buss, Mary K.; Govindan, Ramaswamy; Schiller,
Joan H.; and Cleary, James F., "An eHealth System Supporting Palliative Care for Patients with Non-Small Cell Lung Cancer: A
Randomized Trial" (2013). Community & Leadership Development Faculty Publications. 1.
https://uknowledge.uky.edu/cld_facpub/1
Authors
David H. Gustafson, Lori L. DuBenske, Kang Namkoong, Robert Hawkins, Ming-Yuan Chih, Amy K.
Atwood, Roberta Johnson, Abhik Bhattacharya, Cindy L. Carmack, Anne M. Traynor, Toby C. Campbell,
Mary K. Buss, Ramaswamy Govindan, Joan H. Schiller, and James F. Cleary
An eHealth System Supporting Palliative Care for Patients with Non-Small Cell Lung Cancer: A Randomized
Trial
Notes/Citation Information
Published in Cancer, v. 119, issue 9, p. 1744-1751.
Copyright © 2013 American Cancer Society
This is the accepted version of the following article: Gustafson, D. H., DuBenske, L. L., Namkoong, K.,
Hawkins, R., Chih, M.-Y., Atwood, A. K., Johnson, R., Bhattacharya, A., Carmack, C. L., Traynor, A. M.,
Campbell, T. C., Buss, M. K., Govindan, R., Schiller, J. H. and Cleary, J. F. (2013), An eHealth system
supporting palliative care for patients with non–small cell lung cancer. Cancer, 119: 1744-1751, which has
been published in final form at https://doi.org/10.1002/cncr.27939. This article may be used for non-
commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.
Digital Object Identifier (DOI)
https://doi.org/10.1002/cncr.27939
This article is available at UKnowledge: https://uknowledge.uky.edu/cld_facpub/1
An eHealth System Supporting Palliative Care for Patients with
Nonsmall Cell Lung Cancer: A Randomized Trial
David H. Gustafson, PhD1, Lori L. DuBenske, PhD1,2, Kang Namkoong, PhD3, Robert
Hawkins, PhD4, Ming-Yuan Chih, MHA, MS1, Amy K. Atwood, PhD1, Roberta Johnson, MA,
MEd1, Abhik Bhattacharya, PhD5, Cindy L. Carmack, PhD6, Anne M. Traynor, MD7, Toby C.
Campbell, MD7, Mary K. Buss, MD8, Ramaswamy Govindan, MD9, Joan H. Schiller, MD10,
and James F. Cleary, MD7
1Center for Health Enhancement Systems Studies, University of Wisconsin – Madison
2School of Medicine and Public Health, University of Wisconsin – Madison
3Department of Community and Leadership Development, University of Kentucky, Lexington, KY
4School of Journalism and Mass Communication, University of Wisconsin – Madison
5Blue Health Intelligence, Chicago, Illinois, and formerly Quality Resources Department of
University of Wisconsin Hospital and Clinics
6Department of Behavior Science, M.D. Anderson Cancer Center, Houston, Texas
7Department of Medicine, University of Wisconsin Carbone Cancer Center, Madison, Wisconsin
8Palliative Care and Medical Oncology, Beth Israel Deaconess Medical Center, Boston,
Massachusetts
9Oncology Division, Washington University, St. Louis, Missouri
10Hematology/Oncology Division, University of Texas Southwestern Medical School, Dallas,
Texas, and formerly University of Wisconsin Carbone Cancer Center
Abstract
Background—This study examined the effectiveness of an online support system (CHESS)
versus the Internet in relieving physical symptom distress in patients with nonsmall cell lung
cancer (NSCLC).
Methods—285 informal caregiver-patient dyads were randomly assigned to standard care plus
the Internet or CHESS for up to 25 months. Caregivers agreed to use CHESS or the Internet and
complete bimonthly surveys; for patients, these tasks were optional. The primary endpoint, patient
symptom distress, was measured by caregiver reports using a modified Edmonton Symptom
Assessment Scale (ESAS).
Results—Caregivers in the CHESS arm consistently reported lower patient physical symptom
distress than caregivers in the Internet arm, with significant differences at 4 months (P = .031,
Cohen’s d = .42) and 6 months (P = .004, d = .61). Similar but marginally significant effects were
observed at 2 months (P = .051, d = .39) and 8 months (P = .061, d = .43). Exploratory analyses
showed that survival curves did not differ significantly between the arms (log rank, P = .172),
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although a survival difference in an exploratory subgroup analysis suggests an avenue for further
study.
Conclusions—An online support system may reduce patient symptom distress. The effect on
survival bears further investigation.
Keywords
lung cancer; symptom distress; palliative care; quality of life; survival; eHealth; communication
and information technology
Introduction
Palliative care aims to relieve distress and control symptoms for patients with life-
threatening illnesses such as advanced cancer.1 Although randomized controlled trials
testing the effectiveness of palliative care are scarce,2 several organizations—including the
American Society of Clinical Oncology3 and the Institute of Medicine4— advocate that
palliative care be routinely integrated into standard cancer care. A study by Movsas et al5
suggested that nonsmall cell lung cancer (NSCLC) patients might benefit from interventions
such as those that help manage symptoms and provide social support. A study by Temel6
found that NSCLC patients who received early palliative care with standard oncologic care
had less symptom distress and depression. An exploratory analysis in Temel showed that
patients receiving early palliative care also survived longer by 2.7 months compared to
patients who received only standard care.
Psychosocial interventions also have been used to improve the lives of patients with
advanced cancer.7 Both group and individual interventions have been shown to improve
physical functioning and reduce psychological symptoms.7 Some interventions have
demonstrated an effect on survival,8–10 while others have had less positive results.11–13
Online interventions that include palliative care and psychosocial support have rarely been
studied; even less studied are online interventions aimed at family caregivers.14 This paper
examines the potential benefit of an online information, communication, and coaching
system called CHESS (Comprehensive Health Enhancement Support System)15 that was
designed to support informal caregivers of NSCLC patients. CHESS is a non-commercial
website created by clinical, communication, and systems scientists at the University of
Wisconsin.
We hypothesized that advanced NSCLC patients in caregiver-patient dyads receiving
standard care plus CHESS would have less symptom distress than those receiving standard
care plus the Internet. We also explored the effect of CHESS compared to the Internet on
patient survival.
Methods
Study Design
This paper reports on a multisite, non-blinded randomized trial. Caregiver-patient dyads
were recruited at 4 cancer-center hospitals in the East, Midwest, and Southwest U.S.
between September 2004 and April 2007; data collection ended in May 2009. The study was
approved by the institutional review boards of all centers.
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Participants
Eligible dyads consisted of English-speaking adult patients with NSCLC at stage IIIA, IIIB,
or IV and a patient-identified primary caregiver willing to participate in the study. Patients
had to have a clinician-perceived life expectancy of at least 4 months; if patients had brain
metastasis, it had to be stable. Caregivers provided instrumental, emotional, and/or financial
support for the patient and were at least 18 years old. Dyads were identified by their
oncologist and invited to participate by the enrollment coordinator at each site. After
providing informed consent, caregivers and patients completed pretests eliciting
demographic data and assessing their physical and emotional well-being. Dyads were
randomized to standard care plus either the Internet or CHESS. Caregivers agreed to
complete follow-up surveys every 2 months about their own and the patient’s health.
Completing the surveys and using the computer were optional for patients.
Intervention
Caregiver-patient dyads received the intervention for 25 months or 13 months after patient
death, whichever was less. For example, if a patient died after 4 months in the study, the
caregiver could stay in the study to use bereavement resources for up to 13 months, making
17 months the total time in the study.
Participants in the Internet arm received training on using the Internet and a list of Internet
sites about lung cancer, such as www.lungcanceralliance.org, http://cancernet.nci.nih.gov/
cancertopics/types/lung, and www.lungcanceronline.org. Those in the CHESS arm received
password-protected access to the CHESS “Coping with Lung Cancer” website. CHESS was
designed to be easy to use and: (1) provide well-organized lung cancer, care-giving, and
bereavement information; (2) serve as a channel for communication with and support from
peers, experts, clinicians, and users’ social networks; (3) act as a coach by gathering
information from users and providing feedback based on algorithms (decision rules); and (4)
provide tools (e.g., a program to organize support from family and friends) to improve the
caregiving experience. CHESS included a Clinician Report that summarized caregiver and
patient ratings of the patient’s health status15 and listed their questions for the next clinic
visit. Clinicians received e-mail alerts before a scheduled visit and whenever a symptom
rating exceeded 7 on a 0-to-10 scale. CHESS services are described in more detail
elsewhere.15
Dyads in both arms received computers and Internet service if needed and were reimbursed
for the cost of Internet service during the study. All were offered phone-based technical
assistance to set up the computer and use CHESS or the Internet. At study end, participants
could keep the computers and those assigned to CHESS could continue to use CHESS, but
data collection and reimbursement for Internet service stopped.
Randomization
The study protocol called for 3 arms consisting of standard care plus (1) CHESS with the
Clinician Report, (2) CHESS without the Clinician Report, and (3) the Internet. Because of
low accrual, arm 2 was dropped after 37 dyads were assigned to it to retain the power
needed for analysis and complete the study within the funded timeframe. Those 37 dyads are
not included in this analysis.
A total of 285 caregiver-dyads were randomly assigned to the Internet or CHESS arm (1:1
ratio), with assignment determined at the University of Wisconsin by random numbers. Each
site used a separate randomization schedule. Randomization was blocked by caregiver-
patient relationship (spouse or partner versus other) and minority status (Caucasian versus
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non-Caucasian). Four patients died and 35 dyads withdrew before completing the pretest,
leaving 246 of the 285 randomized dyads to receive the intervention (Figure 1).
Outcomes Examined
Caregiver surveys reporting patient symptom distress were used for two reasons. First,
patients may not have had the energy to complete bimonthly surveys as their health
deteriorated and having a consistent data source throughout the study was important.
Second, while some research suggests that caregivers tend to overestimate patient
distress,16–17 the clinical trial focused on caregivers and how they perceived the situation.
A longitudinal examination of patient symptom distress and patient and caregiver QOL was
planned for the clinical trial. This paper addresses patient symptom distress while the
analysis of caregiver QOL is reported elsewhere.18 We have not analyzed patient QOL
because caregivers felt uncomfortable completing the measure (the McGill Quality of Life
Questionnaire) on behalf of patients given that questions focus on a patient’s internal
psychological experiences.
Pretest and bimonthly follow-up surveys asked caregivers to rate patient symptom distress,
the primary outcome, on a scale of 0 (absence of symptom) to 10 (worst possible symptom)
using a modified Edmonton Symptom Assessment Scale (ESAS).19 The original ESAS
comprises 7 physical and 2 psychological items. Based on feedback from study oncologists,
3 of the original physical symptoms (activity, drowsy, and well-being) were replaced with
common lung cancer symptoms: fatigue, constipation, and diarrhea. Because research has
indicated that the two psychological symptoms (depression and anxiety) may not represent
the full range of patients’ emotional symptoms,20–22 a separate subscale summed responses
for only the 7 physical symptoms. The range of values for the overall ESAS was 0 to 90; for
the physical subscale, it was 0 to 70, with a Cronbach’s α of .722 at pretest. Analyses are
reported on the physical subscale.
Statistical Analysis
Patient symptom distress was examined using ESAS physical symptom distress scores
reported by caregivers at pretest and 2, 4, 6, and 8 months after the intervention started.
With α of .05 and power of .80, a sample of 128 patients would be sufficient to detect a
moderate effect of .5 SD difference in ESAS scores between arms.
A linear mixed-model regression, performed on repeated ESAS scores using IBM SPSS 20,
compared patient symptom distress between arms over time controlling for pretest ESAS
score and site, caregiver-patient relationship, and race. In addition, the model included
effects for arm (CHESS versus Internet), month (2, 4, 6, and 8 months after intervention
start), and arm-by-month interaction. A first-order autoregressive covariance structure was
used for the repeated measure. Fixed effects were calculated using restricted maximum
likelihood estimation, with between-arm tests of estimated marginal means conducted at
each time point.
During the study, we observed that caregivers from the Internet arm were transitioning to
bereavement status more frequently than CHESS-arm caregivers, which prompted an
exploratory survival analysis. Survival was measured from the day the dyads received the
intervention until patient death. Participant were censored if they dropped out of the study
(censored at the drop date), if no further contact with the patient or caregiver could be made
(censored at the last traceable date, e.g., the last medical appointment), or if they lived more
than 2 years (censored at 2 years). Cumulative survival rates were estimated using Kaplan-
Meier analysis. The Cox proportional hazards model was used to understand the influence
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on survival of age, gender, cancer stage, treatment history, and the interval between
diagnosis and intervention.
While the study focused on intention to treat, some participants randomized to the CHESS
arm did not use it. We defined use as proceeding beyond the disclaimer page to something
of value (e.g., discussion group, personal stories), as well as median minutes of CHESS use,
pages viewed, and logins. We did not have data on Internet-arm use.
To explore patient suffering before death, we used the same mixed effects model from the
primary analysis, but with the outcomes being physical ESAS scores from surveys
completed 2, 4, 6, and 8 months before patient death.
RESULTS
Baseline characteristics for each arm are shown in Table 1. Between the randomized arms,
only caregiver’s Internet comfort was significantly different (P = .044), with the CHESS
group being less comfortable.
Primary Analysis: Symptom Distress
Table 2 shows caregiver-reported patient symptom distress. CHESS caregivers reported
significantly lower physical symptom distress than those in the Internet arm (P = .005,
Cohen’s d = .46). Comparisons at each survey month showed this pattern consistently, with
significant differences at 4 (P = .031, d = .42) and 6 months (P = .004, d = .61) and
marginally significant differences at 2 (P = .051, d = .39) and 8 months (P = .061, d = .43).
To examine whether any individual item drove the results of the physical subscale, we
repeated the analysis separately for each symptom. While significant group differences were
observed for all items except nausea, no single item dominated the results.
Exploratory Analyses: Survival, Use of CHESS, and Distress Before Death
Figure 2 shows the Kaplan-Meier survival curves over 24 months. During the 2-year
intervention, 77 of 124 CHESS-arm patients (62%) died and 89 of 122 Internet-arm patients
(73%) died. Median survival was 10.1 months (SE = 1.5) for the Internet arm and 14.8
months (SE = 1.2) for the CHESS arm (log rank, P = .172). A marginally significant
difference in survival was found after adjustment for age, gender, cancer stage, treatment
history, and interval between diagnosis and intervention (adjusted HR, .75; 95% CI, .55–
1.04; P = .083).
In accordance with the CONSORT eHealth checklist,23 we looked at CHESS use among
those with access to it. CHESS was used at least once by 73.4% of caregivers and 50% of
patients, and 51.6% of caregivers and 34.7% of patients used CHESS 5 or more times. The
median number of minutes of CHESS use was 103 for caregivers and 146 for patients; the
median number of pages viewed was 147 for caregivers and 243 for patients; and the median
number of logins was 8 for caregivers and 12 for patients.
To explore the effect of CHESS use on survival, we compared patients who used CHESS (n
= 62) to patient non-users (n = 62) and Internet-arm patients (n = 122). Estimated median
survival for CHESS users was 19.2 months (SE = 3.4) and for CHESS non-users, 9.9
months (SE = 2.7; log rank, P = .003). The difference remained significant after controlling
for age, gender, cancer stage, treatment history, and interval between diagnosis and
intervention (adjusted HR, .49; 95% CI, .28–.84; P = .009). Survival differences were also
significant when comparing CHESS users to those from the Internet arm (log rank, P = .007;
adjusted HR = .58; 95% CI, .38–.89; P = .012].
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CHESS users and non-users were not randomly assigned; they self-selected. We compared
baseline patient ESAS scores and found no significant differences between CHESS users,
CHESS non-users, and the Internet arm. Between CHESS users and non-users at baseline
(Table 1), significant differences were found for caregiver gender (P = .008) and treatment
history (P = .021). A marginally significant difference was found for the percentage of
caregivers who were spouses or partners vs. other (P = .067). Between CHESS users and
Internet patients at baseline, we found one significant difference on caregiver gender (P = .
035) and one marginally significant difference on treatment history (P = .058).
To examine whether the longer survival was accompanied by prolonged suffering, we
compared CHESS users to non-users and to Internet patients on symptom distress at points
related to patient death (e.g., at 2, 4, 6, and 8 months before patient death). No significant
differences between groups were observed, suggesting that longer living patients did not
suffer more.
Discussion
The study demonstrates that an online intervention is associated with reduced patient
symptom distress in advanced lung cancer. Patients randomized to CHESS had significantly
less caregiver-reported physical distress than those in the Internet arm at 4 and 6 months
after intervention start and similar but marginally significant results at 2 and 8 months. An
exploratory analysis found that the two arms did not differ in 2-year survival rates, but
CHESS-arm patients who used the system did survive longer than controls and non-users.
Despite living longer, patients who used CHESS did not suffer more in caregiver-reported
distress in the months before they died.
To our knowledge, this is the only randomized trial of an online system of information,
support, and coaching available 24/7 to lung cancer patients and their caregivers. Project
ENABLE II24 (a telephone-based, nurse-led palliative care intervention) improved QOL in
patients with advanced cancer, giving evidence for a distant though not online intervention.
Our study also overcomes methodological problems2, 7 common in studies of palliative care
and psychosocial interventions. Specifically, the study recruited all eligible patients
diagnosed with NSCLC, not just those referred to palliative or psychosocial interventions;
the sample size provided sufficient power for testing the primary hypothesis; and the
symptom distress measure was appropriate to terminal patients and in fact tailored to
NSCLC patients.
Why might a system chiefly designed for caregivers affect patients? Information in CHESS
may help caregivers provide better informal care, and the Clinician Report may have
allowed both caregivers and clinicians to manage symptoms more effectively.14 (When
caregivers or patients rated patient distress symptoms at 7 or higher, CHESS automatically
sent an email message to clinicians.) With better symptom management, patients may have
been encouraged to adhere to treatment. The Clinician Report may also have enabled
clinicians to better address patient and caregiver concerns during clinic visits. In interviews,
some clinicians reported that caregivers using CHESS were more engaged during clinic
visits and better able to describe their concerns and the patient’s symptoms.14
Given that patients in the two randomized arms were well matched at baseline, they would
seem to have had equal potential for survival, and over the 2-year span of data collection,
the survival curves did not differ. But within the CHESS arm, those who actually used
CHESS were associated with longer survival. It may be that CHESS encourages the
qualities sometimes linked to longer survival, such as active rather than depressive coping25
and high involvement in self-help.26 The psychosocial support in CHESS—the ability of
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patients and caregivers to communicate with peers, 24/7, about others’ treatments and
decisions—also may reduce stress and physical and psychological symptom burden, thereby
leading to improved survival. For example, a CHESS patient (or caregiver) may have
communicated with a patient (or their caregiver) who survived longer than expected,
inspiring closer adherence to treatment recommendations. Although patients in the two arms
had similar symptom distress at baseline, Internet-arm patients had greater symptom distress
during the study, perhaps affecting decisions they made about seeking or adhering to
treatment or their eligibility for further treatment. CHESS users and non-users differed
significantly on treatment history. It may be that users were better off to start than non-users
and therefore well enough to use CHESS. However, ECOG status (a measure of patient
functioning) did not differ at baseline between users and non-users (or between users and the
Internet arm or between randomized arms).
The study has limitations. Patient treatment was not tracked after randomization, and it
could be confounding. At baseline, treatment history was significantly different between
CHESS users and non-users (P = .021) and marginally significantly different between
CHESS users and patients in the Internet arm (P = .058). Although the analysis used
treatment history as a covariate, the survival advantage found for CHESS users may relate to
unmeasured prognostic variables rather than to CHESS use. Patients in both arms lived
longer than patients with advanced lung cancer generally do, probably because, to be
eligible, patients needed a clinician-anticipated survival of at least 4 months. Future studies
will also benefit from having ongoing measures of system use in all groups.
Additional rigorous studies are needed to determine whether online emotional and
instrumental support for both patient and caregiver can ease distress and lengthen survival.
An effective online system of palliative care could offer a low-cost end-of-life intervention
that would be relatively easy to distribute widely.
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Figure 1.
Flow of participants from recruitment to analysis
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Figure 2.
Kaplan-Meier survival curves are shown for (A) the CHESS vs. Internet arms and (B)
CHESS users vs. CHESS non-users vs. Internet participants.
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